Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Transplantation

• Publication date

  1994-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199408000-00010PMID 8053053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of the renin-angiotensin-aldosterone axis with erythropoietin therapy by a negative feedback loop.

  1992cited by this paper
• Effects of enalapril on erythrocytosis after renal transplantation.

  1991cited by this paper
• Factors predictive of post-transplant erythrocytosis

  1991cited by this paper
• Post-transplant erythrocytosis and immunosuppression with cyclosporin: a case-control study.

  1991cited by this paper
• Enalapril-associated anemia in renal transplant recipients treated for hypertension.

  1991cited by this paper
• Role of cytochrome P450 in the control of the production of erythropoietin.

  1990cited by this paper
• Role of excretory graft function for erythropoietin formation after renal transplantation

  1990cited by this paper
• Captopril induces correction of postrenal transplant erythremia

  1990cited by this paper
• Multiple site estimates of erythropoietin and renin in polycythemic kidney transplant patients.

  1990cited by this paper
• Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy.

  1990cited by this paper
• Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation.

  1990cited by this paper
• Anemia and Angiotensin‐Converting Enzyme Inhibition in Renal Transplant Recipients

  1990cited by this paper
• High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril

  1989cited by this paper
• Worsening of Anemia by Angiotensin Converting Enzyme Inhibitors and Its Prevention by Antiestrogenic Steroid in Chronic Hemodialysis Patients

  1989cited by this paper
• Serum erythropoietin levels after renal transplantation.

  1989cited by this paper
• Serum erythropoietin in renal transplant patients.

  1989cited by this paper
• Erythraemia in renal transplant recipients treated with cyclosporin.

  1988cited by this paper
• Erythrocythemia following renal transplantation: influence of diuretic therapy.

  1988cited by this paper
• Dynamics of erythropoiesis following renal transplantation.

  1987cited by this paper
• Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients.

  1986cited by this paper
• Postrenal transplant erythrocytosis: a review of 53 patients.

  1983cited by this paper
• Studies in polycythemia after kidney transplantation.

  1983cited by this paper
• Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia.

  1983cited by this paper
• Effect of angiotensin infusion on extrarenal erythropoietin production.

  1982cited by this paper
• A matched-pair control study of postrenal transplant polycythemia.

  1982cited by this paper
• Interrelation of the renin system and erythropoietin in rats.

  1980cited by this paper
• ARE THE NATIVE KIDNEYS RESPONSIBLE FOR ERYTHROCYTOSIS IN RENAL ALLORECIPIENTS?

  1979cited by this paper
• Effect of renin on extrarenal erythropoietin production.

  1976cited by this paper
• Erythremia after renal transplantation.

  1965cited by this paper

• High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐Converting Enzyme Inhibitor Initiators

  2025cites this paper
• Post-transplant erythrocytosis after kidney transplantation: A review

  2021cites this paper
• Anemia in older persons: etiology and evaluation.

  2011cites this paper
• Renin-angiotensin system polymorphisms and hemoglobin level in renal allografts: a comparative study between losartan and enalapril.

  2007cites this paper
• Clinical and Basic Cardiology Online Data Base Search for Authors and Comparative Effects of Fosinopril and Irbesartan on Haematopoiesis in Essential Hypertension

  2007cites this paper
• Untoward effects of chronic dual renin–angiotensin system blockade: influence of previous chronic renal failure

  2006cites this paper
• Efficacy of Enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation

  2006cites this paper
• A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period.

  2006cites this paper
• Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction.

  2005cites this paper
• Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.

  2005cites this paper
• Regulation der Erythropoetin-Sekretion: Einfluss des endogenen Angiotensins unter salzarmer und salzreicher Ernährung

  2004cites this paper
• Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis.

  2003cites this paper
• The effect of high dose losartan on erythropoietin resistance in patients undergoing haemodialysis.

  2003cites this paper
• Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans?

  2003cites this paper
• Posttransplant erythrocytosis.

  2003cites this paper
• Comparative Effects of Fosinopril and Irbesartan on Hematopoiesis in Essential Hypertensives

  2003cites this paper
• Long-Term Medical Management for Patients with Kidney Transplants

  2002cites this paper
• Postrenal transplant erythrocytosis: risk factors and effectiveness of angiotensin receptor antagonists.

  2002cites this paper
• PERIPHERAL REGULATION OF GRAFT-VERSUS-HOST ALLOREACTIVITY IN MIXED CHIMERIC MINIATURE SWINE

  2001cites this paper
• COMPARISON OF THE EFFECTS OF ENALAPRIL AND LOSARTAN ON POSTTRANSPLANTATION ERYTHROCYTOSIS IN RENAL TRANSPLANT RECIPIENTS: Prospective Randomized Study1

  2001cites this paper
• Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.

  2000cites this paper
• Cardiovascular disease after renal transplantation.

  2000cites this paper
• Dose-dependent effect of angiotensin II on human erythropoietin production

  2000cites this paper
• Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation.

  2000cites this paper
• Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis.

  1999cites this paper
• Angiotensin II increases erythropoietin production in healthy human volunteers

  1999cites this paper
• Postrenal transplant erythrocytosis and insertion/deletion polymorphism of the angiotensin converting enzyme gene.

  1999cites this paper
• Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin.

  1999cites this paper
• Fenoterol stimulates human erythropoietin production via activation of the renin angiotensin system.

  1999cites this paper
• ect of enalapril on exaggerated erythropoietin response to phlebotomy in erythrocytosic renal transplant patients

  1998cites this paper
• Blockade of angiotensin II AT 1 receptor reduces hematocrit in patients with posttransplant erythrocytosis.

  1998cites this paper
• Effect of enalapril on exaggerated erythropoietin response to phlebotomy in erythrocytosic renal transplant patients.

  1998cites this paper
• Posttransplant erythrocytosis: a model for the investigation of the pharmacological control of renal erythropoietin production?

  1996cites this paper
• Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors.

  1996cites this paper
• Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients.

  1996cites this paper
• Vasoactive hormones and renal sclerosis.

  1996cites this paper
• Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.

  1996cites this paper
• Efficacy of enalapril in the treatment of erythrocytosis in patients with renal allografts.

  1996cites this paper
• Comparison of dose requirement, serum erythropoietin and blood pressure following intravenous and subcutaneous erythropoietin treatment of dialysis patients IV and SC erythropoietin

  1996cites this paper
• Clinical assessment of continuous dialysate osmolality and ultrafiltration control in haemodialysis by seven different profiles.

  1996cites this paper